Medite Cancer Diagnostics, Inc. (MDIT) has 9 open-market insider trades by 4 insiders since 2018. The most active filer is William Austin Lewis IV, Director & 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| William Austin Lewis IV | Dir10% Owner | — | 5 | $5.2M | 2018-10-15 |
| Gregory Fortunoff | Dir | — | 1 | $2.0M | 2018-04-04 |
| John H. Abeles | Dir | — | 2 | $53K | 2018-10-11 |
| Stephen L. von Rump | CEO / CFO | — | 1 | $11K | 2018-07-27 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| William Austin Lewis IV | Director & 10% Owner | Buy | $1.4M | 2018-10-15 |
| John H. Abeles | Director | Buy | $21K | 2018-10-11 |
| Stephen L. von Rump | CEO / CFO | Buy | $11K | 2018-07-27 |
| William Austin Lewis IV | Director & 10% Owner | Buy | $88K | 2018-07-25 |
| William Austin Lewis IV | Director & 10% Owner | Buy | $1.1M | 2018-07-09 |
| John H. Abeles | Director | Buy | $32K |
Companies that share insiders with MDIT, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2018-07-03 |
| William Austin Lewis IV | Director & 10% Owner | Buy | $853K | 2018-04-26 |
| Gregory Fortunoff | Director | Buy | $2.0M | 2018-04-04 |
| William Austin Lewis IV | Director | Buy | $1.7M | 2018-02-06 |